Post Profile






Genetic signature linked to cancer prognosis identified

(Medical Research Council) Researchers from the UK's Medical Research Council Cancer Unit at the University of Cambridge have identified a genetic signature related to metabolism associated with poor patient prognosis. The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.
read more

share

Related Posts


Potential Approaches To Combat Aggressive Leukemia Identified By Cancer Sequencing Project

Health : Medical News Today

St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project discovers genetic connection linking 2 cancers that is likely to expand treatments for patients who currently have poor prognoses Researcher...

Diagnosis of cancer as a medical emergency leads to poorer prognosis for many patients

Health : EurekAlert: Health

(University of Cambridge) Too many patients -- particularly those from disadvantaged backgrounds -- are being diagnosed with cancer as medical emergencies, say researchers. This means that their chances of successful treatment are g...

Researchers Identify Four Genetic Variants That Are Linked to Esophageal Cancer and Its Precursor, Barrett's Esophagus

Health : Newswise Medical News

An international consortium co-led by researchers at Fred Hutchinson Cancer Research Center and the QIMR Berghofer Medical Research Institute in Australia has identified four genetic variants associated with an increased risk of eso...

Moffitt Cancer Center Researchers Discover Link between Inherited Genetic Variations, Outcomes of Non-Small Cell Lung Cancer Patients

Health : Newswise Medical News

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Patients diagnosed with NSCLC have a poor prognosis, with a 5-year survival rate of only 16 percent. Researchers at Moffitt Cancer Center hope to improve NSC...

Genomic Analysis Yields Abnormalities Associated with Targeted Treatments in Rare and Poor Prognosis Cancers

Health : Newswise Medical News

Research from Rutgers Cancer Institute of New Jersey shows genomic profiling identifies genomic alterations in tumors that can be associated with targeted treatments for rare and poor prognosis cancers. Preliminary results are being...

Comments


Copyright © 2016 Regator, LLC